Wuxi Biologics: Covid-19 Antibody Products Out By Year End

Aug.18 — Chris Chen, chief executive officer at Wuxi Biologics Cayman Inc., discusses first-half earnings, the progress they’re making on Covid-19 treatments and the company’s expansion plans. He speaks exclusively on “Bloomberg Markets: China Open.”

Watch the video at Bloomberg – Corona Outbreak